New research could provide key to overcoming resistance to HER2 targeted cancer treatments

0 Comments

( Trinity College Dublin ) Scientists from Trinity College Dublin have made a significant discovery of a new biomarker which may help overcome resistance to newer and more targeted anti-cancer drugs, such as Herceptin, for HER2 positive cancers. These findings may also help the early identification of patients who will benefit more from these treatments

View original post here:
New research could provide key to overcoming resistance to HER2 targeted cancer treatments

Leave a Reply